Insights
Perspectives on the choices that shape global patient and commercial value
Strong Evidence Changes the Equation
Exceptional new evidence can challenge assumptions about what is possible. How do you recognize when the old pricing logic no longer applies and build the organizational confidence to pursue a different outcome?
The Comparator Changes the Value
The comparator used to frame an asset can materially influence how its value is perceived. Sometimes changing the reference point changes the opportunity.
One Asset. Different Markets. Different Paths.
Global strategy does not mean pursuing the same solution everywhere. Different evidence requirements, payer systems and market dynamics can require very different paths toward the same broader objective.
Start A Conversation
Have an asset, market or portfolio question where the path forward isn't obvious?
HaywoodMAP works with biotech and pharmaceutical leaders on complex choices across markets and across the portfolio and asset lifecycle.
Let's explore what might be possible